The award was given to Troikaa’s novel technology for topical drug delivery which is commercialised under the brand name Dynapar QPS
Ahmedabad-based Troikaa Pharmaceuticals has bagged the national award from Technology Development Board, Dept of Science & Technology, Govt of India for successful commercialisation indigenous technology. Dr Harsh Vardhan, Union Minister of Science & Technology & Earth Sciences, Government of India conferred upon the award to Ketan R Patel, Chairman and Managing Director, Troikaa Pharmaceuticals on the occasion of Technology Day Celebration in Delhi. The award includes monetary prize of Rs 10 lakhs.
The award was given to Troikaa’s novel technology for topical drug delivery which is commercialised under the brand name Dynapar QPS. It provides quick and comprehensive penetration of the drug through the skin and has brought the paradigm shift in the in the musculoskeletal pain segment.
This novel formulation is a game changer in treating pain in conditions such as osteoarthritis, rheumatoid arthritis, back pain, pain due to repetitive injury, sprains, sports injuries etc. and provides significantly enhanced pain relief as compared to any of the topical pain gels/ creams/ liniments on the market. Superior efficacy of Dynapar QPS enables doctors to substantially reduce the dose of oral NSAIDs thereby sparing the patients from their harmful effects on kidneys, liver and cardiovascular system.
Comments are closed.